CLSDQ — Clearside Biomedical, Share News
0.000.00%
Last trade - 00:00- $1.31m
- $55.68m
- $1.66m
U.S. STOCKS ON THE MOVE-Merck, Genco, Tesla
U.S. STOCKS ON THE MOVE-Morgan Stanley, Merck, Genco
Clearside Biomedical plunges after filing for Chapter 11 bankruptcy
U.S. STOCKS ON THE MOVE-Bristol Myers Squibb, Palo Alto Networks, MP Materials
Brief: Clearside Biomedical To Pursue Sale Of Its Business Through Voluntary Chapter 11 Process
U.S. STOCKS ON THE MOVE-Alibaba, Biogen, Venture Global
Clearside Biomedical plunges after filing for bankruptcy
Brief: Clearside Biomedical Files For Chapter 11 Bankruptcy In US - Court Filing
Brief: Clearside Biomedical Files For 1-For-15 Reverse Stock Split - SEC Filing
Brief: Clearside Biomedical - On Sept 4, Enters Amendment Agreement With Healthcare Royalty Partners - SEC Filing
Clearside Biomedical Inc reports results for the quarter ended June 30 - Earnings Summary
Clearside Biomedical Inc expected to post a loss of 10 cents a share - Earnings Preview
Brief: Clearside Biomedical Announces Approval Of Xipere® Suprachoroidal Treatment For Uveitic Macular Edema In Canada
Brief: Clearside Biomedical Inc - All Employees To Transition To Consulting Roles - SEC Filing
Brief: Clearside Biomedical Announces Plan To Explore Strategic Alternatives To Advance Its Proprietary Suprachoroidal Space (Scs®) Delivery Platform And Promising Ophthalmology Pipeline
Clearside Biomedical Inc reports results for the quarter ended March 31 - Earnings Summary
Clearside Biomedical Inc expected to post a loss of 11 cents a share - Earnings Preview
Clearside Biomedical Inc expected to post a loss of 11 cents a share - Earnings Preview
Clearside Biomedical Inc reports results for the quarter ended December 31 - Earnings Summary